Alpha 2.0
Login Register
» Authors » J R BOISSIER

J R BOISSIER

Explore the profile of J R BOISSIER including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 313
Citations 682
Followers 0
Related Specialties
Pharmacology
Biology
Pharmacy
Top 10 Co-Authors
P Simon
C Dumont
J F Giudicelli
J P Tillement
S Larno
P VIARS
R Hazard
P MOUILLE
R RATOUIS
J M LWOFF
Published In
Therapie
Ann Pharm Fr
C R Seances Soc Biol Fil
Eur J Pharmacol
Arch Int Pharmacodyn Ther
Affiliations
Soon will be listed here.
Recent Articles
1.
[Demonstration of anxiolytic action using "psychic" stress (stress caused by noise)]
Boaventura A, Mouren M, BOISSIER J
J Pharmacol . 1986 Jul; 17(3):369-74. PMID: 2879070
No abstract available.
2.
Effects of the new eburnamenine derivative RU 24722 on EEG recovery and cerebral energy metabolism after complete ischemia
Barzaghi F, DRAGONETTI M, Formento M, BOISSIER J
Arzneimittelforschung . 1985 Jan; 35(2):472-7. PMID: 4039569
The influence of a new eburnamenine derivative RU 24722 [(3 beta, 14 alpha, 16 alpha)-(+/-)-14,15-dihydro-20,21-dinoreburnamenin -14-ol] on post-ischemic EEG recovery was studied in N2O anesthetized rats subjected to 1 min...
3.
Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation
Oberlander C, BOISSIER J
J Pharmacol . 1983 Oct; 14(4):401-4. PMID: 6423905
The effects of the (+) and (-) enantiomers of 3-PPP on striatal postsynaptic dopaminergic (DAergic) receptors were studied using two rotation behaviour models in the rat. After unilateral deafferentation of...
4.
Synthesis and central dopaminergic activities of (+/-)-hexahydro-7H-indolo[3,4-gh][1,4]benzoxazine derivatives [(+/-)-9-oxaergolines]
NEDELEC L, PIERDET A, Fauveau P, Euvrard C, Dumont C, Labrie F, et al.
J Med Chem . 1983 Apr; 26(4):522-7. PMID: 6834383
The synthesis and biological activities of a series of (+/-)-hexahydro-7H-indolo[3,4-gh][1,4]benzoxazine derivatives [(+/-)-trans-9-oxaergolines] with central dopamine (DA) agonist properties are described. The compounds were prepared from [2aRS-(2a alpha,4 beta,5 alpha)]-4-amino-1,2,2a,3,4, 5-hexahydro-1-(phenylmethyl)benz[cd]indol-5-ol...
5.
Comparative study of central dopaminergic properties of RU 29717 (N-propyl-9-oxaergoline) and pergolide
BOISSIER J, Euvrard C, Oberlander C, Laurent J, Dumont C, Labrie F
Eur J Pharmacol . 1983 Feb; 87(2-3):183-9. PMID: 6857756
RU 29717, a 9-oxaergoline derivative, has been compared with pergolide in a variety of biochemical and behavioural tests indicative of dopaminergic (DAergic) activity. RU 29717 and pergolide have a similar...
6.
Cerebral energy metabolism and computerized EEG. Analysis following transient ischemia in the rat
Barzaghi F, DRAGONETTI M, Formento M, BOISSIER J
J Pharmacol . 1982 Oct; 13(4):553-63. PMID: 7154667
1. Cerebral energy metabolism and electroencephalogram (EEG) power spectra were evaluated before, during and after 1 minute of global compression ischemia induced in N2O anesthetized rats. 2. Before ischemia, the...
7.
Interaction of estrogens and the dopaminergic system
BOISSIER J, Euvrard C, Labrie F
Acta Physiol Pharmacol Bulg . 1982 Jan; 8(1-2):50-7. PMID: 7124419
No abstract available.
8.
Age-related changes in central nervous system enkephalins and substance P
Dupont A, Savard P, Merand Y, Labrie F, BOISSIER J
Life Sci . 1981 Nov; 29(22):2317-22. PMID: 6172689
No abstract available.
9.
Dopamine independent rotational response to unilateral intranigral injection of serotonin
Oberlander C, HUNT P, Dumont C, BOISSIER J
Life Sci . 1981 Jun; 28(23):2595-601. PMID: 7266239
No abstract available.
10.
Anorectic properties of a new long acting serotonin uptake inhibitor
Dumont C, Laurent J, Grandadam A, BOISSIER J
Life Sci . 1981 Apr; 28(17):1939-45. PMID: 7253801
No abstract available.